Abstract

We conducted voluntary Covid-19 testing programmes for symptomatic and asymptomatic staff at a UK teaching hospital using naso-/oro-pharyngeal PCR testing and immunoassays for IgG antibodies. 1128/10,034(11.2%) staff had evidence of Covid-19 at some time. Using questionnaire data provided on potential risk-factors, staff with a confirmed household contact were at greatest risk (adjusted odds ratio [aOR] 4.82 [95%CI 3.45-6.72]). Higher rates of Covid-19 were seen in staff working in Covid-19-facing areas (22.6% vs. 8.6% elsewhere) (aOR 2.47 [1.99-3.08]). Controlling for Covid-19-facing status, risks were heterogenous across the hospital, with higher rates in acute medicine (1.52 [1.07-2.16]) and sporadic outbreaks in areas with few or no Covid-19 patients. Covid-19 intensive care unit staff were relatively protected (0.44 [0.28-0.69]), likely by a bundle of PPE-related measures. Positive results were more likely in Black (1.66 [1.25-2.21]) and Asian (1.51 [1.28-1.77]) staff, independent of role or working location, and in porters and cleaners (2.06 [1.34-3.15]).

Data availability

The data studied are available from the Infections in Oxfordshire Research Database (https://oxfordbrc.nihr.ac.uk/research-themes-overview/antimicrobial-resistance-and-modernising-microbiology/infections-in-oxfordshire-research-database-iord/), subject to an application and research proposal meeting the ethical and governance requirements of the Database. For further details on how to apply for access to the data and for a research proposal template please email iord@ndm.ox.ac.uk.

Article and author information

Author details

  1. David W Eyre

    Big Data Institute, University of Oxford, Oxford, United Kingdom
    For correspondence
    david.eyre@bdi.ox.ac.uk
    Competing interests
    David W Eyre, Lecture fees from Gilead, outside the submitted work.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0001-5095-6367
  2. Sheila F Lumley

    Clinical infection, Oxford University Hospitals, Oxford, United Kingdom
    Competing interests
    No competing interests declared.
  3. Denise O'Donnell

    Nuffield Department of Medicine, University of Oxford, Oxford, United Kingdom
    Competing interests
    No competing interests declared.
  4. Mark Campbell

    Clinical infection, Oxford University Hospitals, Oxford, United Kingdom
    Competing interests
    No competing interests declared.
  5. Elizabeth Sims

    Occupational Health, Oxford University Hospitals, Oxford, United Kingdom
    Competing interests
    No competing interests declared.
  6. Elaine Lawson

    Occupational Health, Oxford University Hospitals, Oxford, United Kingdom
    Competing interests
    No competing interests declared.
  7. Fiona Warren

    Occupational Health, Oxford University Hospitals, Oxford, United Kingdom
    Competing interests
    No competing interests declared.
  8. Tim James

    Clinical Biochemstry, Oxford University Hospitals, Oxford, United Kingdom
    Competing interests
    No competing interests declared.
  9. Stuart Cox

    Clinical Biochemistry, Oxford University Hospitals, Oxford, United Kingdom
    Competing interests
    No competing interests declared.
  10. Alison Howarth

    Nuffield Department of Medicine, University of Oxford, Oxford, United Kingdom
    Competing interests
    No competing interests declared.
  11. George Doherty

    Nuffield Department of Medicine, University of Oxford, Oxford, United Kingdom
    Competing interests
    No competing interests declared.
  12. Stephanie B Hatch

    Nuffield Department of Medicine, University of Oxford, Oxford, United Kingdom
    Competing interests
    No competing interests declared.
  13. James Kavanagh

    Nuffield Department of Medicine, University of Oxford, Oxford, United Kingdom
    Competing interests
    No competing interests declared.
  14. Kevin K Chau

    Nuffield Department of Medicine, University of Oxford, Oxford, United Kingdom
    Competing interests
    No competing interests declared.
  15. Philip W Fowler

    Nuffield Department of Medicine, University of Oxford, Oxford, United Kingdom
    Competing interests
    No competing interests declared.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0003-0912-4483
  16. Jeremy Swann

    Nuffield Department of Medicine, University of Oxford, Oxford, United Kingdom
    Competing interests
    No competing interests declared.
  17. Denis Volk

    Nuffield Department of Medicine, University of Oxford, Oxford, United Kingdom
    Competing interests
    No competing interests declared.
  18. Fan Yang-Turner

    Nuffield Department of Medicine, University of Oxford, Oxford, United Kingdom
    Competing interests
    No competing interests declared.
  19. Nicole Stoesser

    Nuffield Department of Medicine, University of Oxford, Oxford, United Kingdom
    Competing interests
    No competing interests declared.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-4508-7969
  20. Philippa C Matthews

    Nuffield Department of Medicine, University of Oxford, Oxford, United Kingdom
    Competing interests
    No competing interests declared.
  21. Maria Dudareva

    Clinical infection, Oxford University Hospitals, Oxford, United Kingdom
    Competing interests
    No competing interests declared.
  22. Timothy Davies

    Clinical infection, Oxford University Hospitals, Oxford, United Kingdom
    Competing interests
    No competing interests declared.
  23. Robert H Shaw

    Clinical infection, Oxford University Hospitals, Oxford, United Kingdom
    Competing interests
    No competing interests declared.
  24. Leon Peto

    Nuffield Department of Medicine, University of Oxford, Oxford, United Kingdom
    Competing interests
    No competing interests declared.
  25. Louise O Downs

    Clinical infection, Oxford University Hospitals, Oxford, United Kingdom
    Competing interests
    No competing interests declared.
  26. Alexander Vogt

    Clinical infection, Oxford University Hospitals, Oxford, United Kingdom
    Competing interests
    No competing interests declared.
  27. Ali Amini

    Clinical infection, Oxford University Hospitals, Oxford, United Kingdom
    Competing interests
    No competing interests declared.
  28. Bernadette C Young

    Nuffield Department of Medicine, University of Oxford, Oxford, United Kingdom
    Competing interests
    No competing interests declared.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0001-6071-6770
  29. Philip George Drennan

    Clinical infection, Oxford University Hospitals, Oxford, United Kingdom
    Competing interests
    No competing interests declared.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0003-3367-3335
  30. Alexander J Mentzer

    Oxford University Hospitals NHS Foundation Trust, Oxford, United Kingdom
    Competing interests
    No competing interests declared.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-4502-2209
  31. Donal T Skelly

    Nuffield Department of Clinical Neurosciences, University of Oxford, Oxford, United Kingdom
    Competing interests
    No competing interests declared.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-2426-3097
  32. Fredrik Karpe

    NIHR Oxford Biomedical Research Centre, University of Oxford, Oxford, United Kingdom
    Competing interests
    No competing interests declared.
  33. Matt J Neville

    Oxford Centre for Diabetes, Endocrinology and Metabolism, Radcliffe Department of Medicine, University of Oxford, Oxford, United Kingdom
    Competing interests
    No competing interests declared.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-6004-5433
  34. Monique Andersson

    Clinical infection, Oxford University Hospitals, Oxford, United Kingdom
    Competing interests
    No competing interests declared.
  35. Andrew J Brent

    Clinical infection, Oxford University Hospitals, Oxford, United Kingdom
    Competing interests
    No competing interests declared.
  36. Nicola Jones

    Clinical infection, Oxford University Hospitals, Oxford, United Kingdom
    Competing interests
    No competing interests declared.
  37. Lucas Martins Ferreira

    Nuffield Department of Medicine, University of Oxford, Oxford, United Kingdom
    Competing interests
    No competing interests declared.
  38. Thomas Christott

    Nuffield Department of Medicine, University of Oxford, Oxford, United Kingdom
    Competing interests
    No competing interests declared.
  39. Brian D Marsden

    NDM, University of Oxford, Oxford, United Kingdom
    Competing interests
    No competing interests declared.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-1937-4091
  40. Sarah Hoosdally

    Nuffield Department of Medicine, University of Oxford, Oxford, United Kingdom
    Competing interests
    No competing interests declared.
  41. Richard Cornall

    Nuffield Department of Medicine, University of Oxford, Oxford, United Kingdom
    Competing interests
    No competing interests declared.
  42. Derrick W Crook

    Nuffield Department of Medicine, University of Oxford, Oxford, United Kingdom
    Competing interests
    No competing interests declared.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-0590-2850
  43. David I Stuart

    Nuffield Department of Medicine, Oxford University, Oxford, United Kingdom
    Competing interests
    No competing interests declared.
  44. Gavin Screaton

    Nuffield Department of Medicine, University of Oxford, Oxford, United Kingdom
    Competing interests
    No competing interests declared.
  45. Oxford University Hospitals Staff Testing Group

  46. Timothy EA Peto

    Nuffield Department of Medicine, University of Oxford, Oxford, United Kingdom
    Competing interests
    No competing interests declared.
  47. Bruno Holthof

    Corporate, Oxford University Hospitals, Oxford, United Kingdom
    Competing interests
    No competing interests declared.
  48. Anne-Marie O'Donnell

    Occupational Health, Oxford University Hospitals, Oxford, United Kingdom
    Competing interests
    No competing interests declared.
  49. Daniel Ebner

    Target Discovery Institute, University of Oxford, Oxford, United Kingdom
    Competing interests
    No competing interests declared.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-6495-7026
  50. Christopher P Conlon

    Nuffield Department of Medicine, University of Oxford, Oxford, United Kingdom
    Competing interests
    No competing interests declared.
  51. Katie Jeffery

    Oxford University Hospitals NHS Foundation Trust, Oxford, United Kingdom
    Competing interests
    No competing interests declared.
  52. Timothy M Walker

    Nuffield Department of Medicine, University of Oxford, Oxford, United Kingdom
    Competing interests
    No competing interests declared.

Funding

UK Government: Department of Health and Social Care

  • David W Eyre
  • Sheila F Lumley
  • Denise O'Donnell
  • Mark Campbell
  • Elizabeth Sims
  • Elaine Lawson
  • Fiona Warren
  • Tim James
  • Stuart Cox
  • Alison Howarth
  • George Doherty
  • Stephanie B Hatch
  • James Kavanagh
  • Kevin K Chau
  • Philip W Fowler
  • Jeremy Swann
  • Denis Volk
  • Fan Yang-Turner
  • Nicole Stoesser
  • Philippa C Matthews
  • Maria Dudareva
  • Timothy Davies
  • Robert H Shaw
  • Leon Peto
  • Louise O Downs
  • Alexander Vogt
  • Ali Amini
  • Bernadette C Young
  • Philip George Drennan
  • Alexander J Mentzer
  • Donal T Skelly
  • Fredrik Karpe
  • Matt J Neville
  • Monique Andersson
  • Andrew J Brent
  • Nicola Jones
  • Lucas Martins Ferreira
  • Thomas Christott
  • Brian D Marsden
  • Sarah Hoosdally
  • Richard Cornall
  • Derrick W Crook
  • David I Stuart
  • Gavin Screaton
  • Timothy EA Peto
  • Bruno Holthof
  • Anne-Marie O'Donnell
  • Daniel Ebner
  • Christopher P Conlon
  • Katie Jeffery
  • Timothy M Walker

Wellcome Trust Clinical Research Training Fellow (216417/Z/19/Z)

  • Ali Amini

NIHR Clinical Lecturer

  • Bernadette C Young

Structural Genomics Consortium

  • Lucas Martins Ferreira
  • Thomas Christott
  • Brian D Marsden

Kennedy Trust for Rheumatology Research

  • Brian D Marsden

Wellcome Trust Senior Investigator

  • Gavin Screaton

Schmidt Foundation

  • Gavin Screaton

Wellcome Trust Career Development Fellow (214560/Z/18/Z)

  • Timothy M Walker

National Institute of Health Research Health Protection Research Unit in Healthcare Associated Infections and Antimicrobial Resistance (HPRU-2012-10041)

  • David W Eyre
  • Sheila F Lumley
  • Denise O'Donnell
  • Mark Campbell
  • Elizabeth Sims
  • Elaine Lawson
  • Fiona Warren
  • Tim James
  • Stuart Cox
  • Alison Howarth
  • George Doherty
  • Stephanie B Hatch
  • James Kavanagh
  • Kevin K Chau
  • Philip W Fowler
  • Jeremy Swann
  • Denis Volk
  • Fan Yang-Turner
  • Nicole Stoesser
  • Philippa C Matthews
  • Maria Dudareva
  • Timothy Davies
  • Robert H Shaw
  • Leon Peto
  • Louise O Downs
  • Alexander Vogt
  • Ali Amini
  • Bernadette C Young
  • Philip George Drennan
  • Alexander J Mentzer
  • Donal T Skelly
  • Fredrik Karpe
  • Matt J Neville
  • Monique Andersson
  • Andrew J Brent
  • Nicola Jones
  • Lucas Martins Ferreira
  • Thomas Christott
  • Brian D Marsden
  • Sarah Hoosdally
  • Richard Cornall
  • Derrick W Crook
  • David I Stuart
  • Gavin Screaton
  • Timothy EA Peto
  • Bruno Holthof
  • Anne-Marie O'Donnell
  • Daniel Ebner
  • Christopher P Conlon
  • Katie Jeffery
  • Timothy M Walker

Robertson Foundation

  • David W Eyre

NIHR Oxford BRC Senior Fellow

  • David W Eyre
  • Philippa C Matthews

Wellcome Trust Clinical Research Fellow

  • Sheila F Lumley

Medical Research Council (MR/N00065X/1)

  • David I Stuart

Wellcome Trust Intermediate Fellowship (110110/Z/15/Z)

  • Philippa C Matthews

NIHR Doctoral Research Fellow

  • Maria Dudareva

Medical Research Foundation (MRF-145-004-TPG-AVISO)

  • Kevin K Chau

The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.

Ethics

Human subjects: All asymptomatic staff data collection and testing were part of enhanced hospital infection prevention and control measures instituted by the UK Department of Health and Social Care (DHSC). Deidentified data from staff testing and patients were obtained from the Infections in Oxfordshire Research Database (IORD) which has generic Research Ethics Committee, Health Research Authority and Confidentiality Advisory Group approvals (19/SC/0403, ECC5-017(A)/2009). De-identified patient data extracted included admission and discharge dates, ward location and positive Covid-19 test results.

Copyright

© 2020, Eyre et al.

This article is distributed under the terms of the Creative Commons Attribution License permitting unrestricted use and redistribution provided that the original author and source are credited.

Metrics

  • 5,398
    views
  • 647
    downloads
  • 185
    citations

Views, downloads and citations are aggregated across all versions of this paper published by eLife.

Download links

A two-part list of links to download the article, or parts of the article, in various formats.

Downloads (link to download the article as PDF)

Open citations (links to open the citations from this article in various online reference manager services)

Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)

  1. David W Eyre
  2. Sheila F Lumley
  3. Denise O'Donnell
  4. Mark Campbell
  5. Elizabeth Sims
  6. Elaine Lawson
  7. Fiona Warren
  8. Tim James
  9. Stuart Cox
  10. Alison Howarth
  11. George Doherty
  12. Stephanie B Hatch
  13. James Kavanagh
  14. Kevin K Chau
  15. Philip W Fowler
  16. Jeremy Swann
  17. Denis Volk
  18. Fan Yang-Turner
  19. Nicole Stoesser
  20. Philippa C Matthews
  21. Maria Dudareva
  22. Timothy Davies
  23. Robert H Shaw
  24. Leon Peto
  25. Louise O Downs
  26. Alexander Vogt
  27. Ali Amini
  28. Bernadette C Young
  29. Philip George Drennan
  30. Alexander J Mentzer
  31. Donal T Skelly
  32. Fredrik Karpe
  33. Matt J Neville
  34. Monique Andersson
  35. Andrew J Brent
  36. Nicola Jones
  37. Lucas Martins Ferreira
  38. Thomas Christott
  39. Brian D Marsden
  40. Sarah Hoosdally
  41. Richard Cornall
  42. Derrick W Crook
  43. David I Stuart
  44. Gavin Screaton
  45. Oxford University Hospitals Staff Testing Group
  46. Timothy EA Peto
  47. Bruno Holthof
  48. Anne-Marie O'Donnell
  49. Daniel Ebner
  50. Christopher P Conlon
  51. Katie Jeffery
  52. Timothy M Walker
(2020)
Differential occupational risks to healthcare workers from SARS-CoV-2 observed during a prospective observational study
eLife 9:e60675.
https://doi.org/10.7554/eLife.60675

Share this article

https://doi.org/10.7554/eLife.60675

Further reading

    1. Epidemiology and Global Health
    2. Genetics and Genomics
    Tianyu Zhao, Hui Li ... Li Chen
    Research Article

    Alzheimer’s disease (AD) is a complex degenerative disease of the central nervous system, and elucidating its pathogenesis remains challenging. In this study, we used the inverse-variance weighted (IVW) model as the major analysis method to perform hypothesis-free Mendelian randomization (MR) analysis on the data from MRC IEU OpenGWAS (18,097 exposure traits and 16 AD outcome traits), and conducted sensitivity analysis with six models, to assess the robustness of the IVW results, to identify various classes of risk or protective factors for AD, early-onset AD, and late-onset AD. We generated 400,274 data entries in total, among which the major analysis method of the IVW model consists of 73,129 records with 4840 exposure traits, which fall into 10 categories: Disease, Medical laboratory science, Imaging, Anthropometric, Treatment, Molecular trait, Gut microbiota, Past history, Family history, and Lifestyle trait. More importantly, a freely accessed online platform called MRAD (https://gwasmrad.com/mrad/) has been developed using the Shiny package with MR analysis results. Additionally, novel potential AD therapeutic targets (CD33, TBCA, VPS29, GNAI3, PSME1) are identified, among which CD33 was positively associated with the main outcome traits of AD, as well as with both EOAD and LOAD. TBCA and VPS29 were negatively associated with the main outcome traits of AD, as well as with both EOAD and LOAD. GNAI3 and PSME1 were negatively associated with the main outcome traits of AD, as well as with LOAD, but had no significant causal association with EOAD. The findings of our research advance our understanding of the etiology of AD.

    1. Epidemiology and Global Health
    Xiaoning Wang, Jinxiang Zhao ... Dong Liu
    Research Article

    Artificially sweetened beverages containing noncaloric monosaccharides were suggested as healthier alternatives to sugar-sweetened beverages. Nevertheless, the potential detrimental effects of these noncaloric monosaccharides on blood vessel function remain inadequately understood. We have established a zebrafish model that exhibits significant excessive angiogenesis induced by high glucose, resembling the hyperangiogenic characteristics observed in proliferative diabetic retinopathy (PDR). Utilizing this model, we observed that glucose and noncaloric monosaccharides could induce excessive formation of blood vessels, especially intersegmental vessels (ISVs). The excessively branched vessels were observed to be formed by ectopic activation of quiescent endothelial cells (ECs) into tip cells. Single-cell transcriptomic sequencing analysis of the ECs in the embryos exposed to high glucose revealed an augmented ratio of capillary ECs, proliferating ECs, and a series of upregulated proangiogenic genes. Further analysis and experiments validated that reduced foxo1a mediated the excessive angiogenesis induced by monosaccharides via upregulating the expression of marcksl1a. This study has provided new evidence showing the negative effects of noncaloric monosaccharides on the vascular system and the underlying mechanisms.